• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: avacopan
Date Designated: 03/20/2017
Orphan Designation: Treatment of C3 glomerulopathy
Orphan Designation Status: Designated/Designation Withdrawn or Revoked
Date Designation Withdrawn or Revoked: 02/05/2024
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
ChemoCentryx, Inc.
850 Maude Avenue
Mountain View, California 94043
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.